Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells - PubMed (original) (raw)
. 1985 Jan;313(5999):241-3.
doi: 10.1038/313241a0.
- PMID: 3918269
- DOI: 10.1038/313241a0
Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells
L S Mulcahy et al. Nature. 1985 Jan.
Abstract
Human tumours often contain DNA sequences not found in normal tissues which are able to transform cultured NIH 3T3 cells. In some tumours the gene responsible for this transformation belongs to the cellular ras gene family. A specific type of mutation is responsible for converting the cellular proto-oncogene into a ras oncogene capable of inducing transformation. In a study of the function of a cellular ras gene, its protein product (produced in a bacterial cell) was microinjected into NIH 3T3 cells; the recipient cells became morphologically transformed and were induced to initiate DNA synthesis in the absence of added serum, but only when cellular ras protein was injected at much higher concentrations than required with protein of the transforming ras gene. To further analyse the function of the cellular ras gene, we have now injected monoclonal antibodies against ras proteins into NIH 3T3 cells. We report here that NIH 3T3 cells induced to divide by adding serum to the culture medium are unable to enter the S phase of the cell cycle after microinjection of anti-ras antibody, showing that the protein product of the ras proto-oncogene is required for initiation of the S-phase in NIH 3T3 cells.
Similar articles
- Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.
Matyas GR, Fishman PH. Matyas GR, et al. Cell Signal. 1989;1(4):395-404. doi: 10.1016/0898-6568(89)90058-2. Cell Signal. 1989. PMID: 2561989 - Requirement for c-ras proteins during viral oncogene transformation.
Smith MR, DeGudicibus SJ, Stacey DW. Smith MR, et al. Nature. 1986 Apr 10-16;320(6062):540-3. doi: 10.1038/320540a0. Nature. 1986. PMID: 2938016 Free PMC article. - Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.
Feramisco JR, Clark R, Wong G, Arnheim N, Milley R, McCormick F. Feramisco JR, et al. Nature. 1985 Apr 18-24;314(6012):639-42. doi: 10.1038/314639a0. Nature. 1985. PMID: 2581140 - Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
Stacey DW, Kung HF. Stacey DW, et al. Nature. 1984 Aug 9-15;310(5977):508-11. doi: 10.1038/310508a0. Nature. 1984. PMID: 6611509 - The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS. Cooper CS. Environ Health Perspect. 1991 Jun;93:33-40. doi: 10.1289/ehp.919333. Environ Health Perspect. 1991. PMID: 1685444 Free PMC article. Review.
Cited by
- Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.
Stacey DW, Feig LA, Gibbs JB. Stacey DW, et al. Mol Cell Biol. 1991 Aug;11(8):4053-64. doi: 10.1128/mcb.11.8.4053-4064.1991. Mol Cell Biol. 1991. PMID: 2072908 Free PMC article. - Mechanism of intracellular calcium oscillations in fibroblasts expressing the ras oncogene.
Wöll E, Waldegger S, Lang F, Maly K, Grunicke H. Wöll E, et al. Pflugers Arch. 1992 Feb;420(2):208-12. doi: 10.1007/BF00374992. Pflugers Arch. 1992. PMID: 1620579 - A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene.
Sternberg EA, Spizz G, Perry ME, Olson EN. Sternberg EA, et al. Mol Cell Biol. 1989 Feb;9(2):594-601. doi: 10.1128/mcb.9.2.594-601.1989. Mol Cell Biol. 1989. PMID: 2651901 Free PMC article. - Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene.
Lin AH, Groppi VE, Gorman RR. Lin AH, et al. Mol Cell Biol. 1988 Nov;8(11):5052-5. doi: 10.1128/mcb.8.11.5052-5055.1988. Mol Cell Biol. 1988. PMID: 3145405 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources